Published in Women's Health Weekly, August 23rd, 2007
"Lapatinib is associated with some toxicity, but for the most part it is highly manageable," comments Dr. Beverly Moy of Massachusetts General Hospital Cancer Center, Boston, who coauthored the new article along with Dr. Paul E. Goss. "We're hoping to provide some guidance in managing the unique side effects of this medication."
Lapatinib is one of a new class of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly